Member access

4-Traders Homepage  >  Shares  >  Euronext Paris  >  BioAlliance Pharma SA    C4X   

 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Company
Onxeo SA engages in the development of drugs for the treatment of cancer. The firm produces and develops ophan oncology products under the brand names Livatag, Validive, Beleodaq, and AMEP. It also offers specialty products under the brand names Loramyc/Oravig, Sitavig, and Fluriad. The company was... 
Sector
Pharmaceuticals
Calendar
09/10Earnings Call
More about the company
Financials (€)
Sales 2014 17,1 M
EBIT 2014 -1,82 M
Net income 2014 -1,66 M
Finance 2014 37,0 M
Yield 2014 -
Sales 2015 5,02 M
EBIT 2015 -15,0 M
Net income 2015 -15,6 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 9,69x
Capi. / Sales 2015 40,5x
Capitalization 203 M
More Financials
Latest news on BIOALLIANCE PHARMA SA
4d ago ONXEO : strengthens Beleodaq® patent protection in the U.S. until 2027 – O..
4d ago ONXEO : Key milestones and consolidated accounts – First six months 2014 /..
08/06 BIOALLIANCE PHARMA : Data on Dermatology Drugs Detailed by Researchers at BioAll..
07/29 BIOALLIANCE PHARMA : Partner Innocutis Introduces Sitavig in U.S.
07/28 TOPOTARGET A/S : BioAlliance Pharma and Topotarget: Cross-Border Merger Now lega..
07/28 TOPOTARGET A/S : BioAlliance Pharma and Topotarget Confirm Cross-border Merger
07/24 BIOALLIANCE PHARMA : Partner Innocutis Launches Sitavig in U.S.
07/24 BIOALLIANCE PHARMA : Introduces Sitavig in the U.S. by Partner Innocutis
07/09 BIOALLIANCE PHARMA : FDA approval of Beleodaq™ belinostat
05/22 BIOALLIANCE PHARMA : Livatag Gets FDA Fast Track Designation for Treatment of Pr..
05/22 BIOALLIANCE PHARMA : Livatag Given Fast Track Designation by the FDA for the Tre..
05/21 BIOALLIANCE PHARMA : Definitive Merger Plan between BioAlliance Pharma and Topot..
More news
Comments 
Advertisement
Income Statement Evolution
BioAlliance Pharma SA : Income Statement Evolution
More Financials
EPS Revisions
BioAlliance Pharma SA : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF